Advertisement.

OTLC Projected Dividend Yield

Oncotelic Therapeutics Inc ( OTCBB : OTLC )

Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing drugs for orphan oncology indications and cancer treatment. Its eight primary programs include AL-101 for Parkinson's Disease, erectile dysfunction, and female sexual dysfunction; CA4P for solid tumors, focusing on melanoma; Oxi4503 for liquid tumors, focusing on childhood leukemia; OT-101, an antisense drug for various cancers and viruses, including SARS and COVID-19; and Artemisini, a natural derivative that inhibits virus multiplication.

21 YEAR PERFORMANCE RESULTS

OTLC Dividend History Detail
OTLC Dividend News
OTLC Competitors News

# of Shares: 0

Closing Price: 0.06

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
2027	0.00	0%	0	$ 0.00	0.00%
2028	0.00	0%	0	$ 0.00	0.00%
2029	0.00	0%	0	$ 0.00	0.00%
2030	0.00	0%	0	$ 0.00	0.00%
2031	0.00	0%	0	$ 0.00	0.00%
2032	0.00	0%	0	$ 0.00	0.00%
2033	0.00	0%	0	$ 0.00	0.00%
2034	0.00	0%	0	$ 0.00	0.00%
2035	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000